Published in Blood Weekly, June 8th, 2006
In a recently published report, investigators conducted a study to "evaluate selected molecular tests in diagnosis and screening of cytomegalovirus (CMV) infection in immunosuppressed patients. Clinical and cost-effectiveness were assessed through a prospective two-stage trial of CMV screening regimes in a routine service setting.
"Different molecular test results were fed back to clinicians in each stage, plus antigenemia results. The technical performance of the molecular methods was assessed through an independent masked comparison of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.